2014 | 2013 Archive Press Releases | Amarex Taiwan

2013 - ARCHIVE PRESS RELEASES

Dec 17, 2014

Amarex Clinical Research Site Passes Surprise FDA Audit for a Multicenter, Randomized-Controlled Clinical Trial in Surgical Wound Healing and Cosmesis Study Submitted to FDA for Approval

Dec 10, 2014

Amarex and SyneuRx announce FDA approval of Breakthrough designation for Schizophrenia treatment

Nov 12, 2014

Amarex achieves exceptionally fast enrollment completion, ahead of schedule, for a Diabetic Neuropathy Clinical Trial

◄

1 / 3

►

Please reload

2014 - ARCHIVE PRESS RELEASES

Dec 04, 2013

Amarex Founder and CEO Dr. Kazem Kazempour appointed to George Washington University's Regulatory Affairs Advisory Board

Oct 08, 2013

Successful FDA Meeting Advances Botonical Drug to Phase II Study

Sep 14, 2013

Amarex and Montgomery College are again collaborating! The Clinical Trial Project Management course begins on this date

◄

1 / 2

►

Please reload